Page 11 - Pharma
India rejects 955 pharma patent applications in last 3 years
Nirmala Sitharaman said there was a slowdown in exports from SEZs because of reasons like withdrawal of exemptions of minimum alternate tax
 "India rejects 955 pharma patent applications in last 3 years")
Nifty Pharma index hits 2016 highs
Aurobindo Pharma, Cipla, Cadila and Sun Pharma from the Nifty Pharma index were up 1% each on the NSE.
 "Nifty Pharma index hits 2016 highs")
Pharma recovers, tech lags after Brexit
Pharmaceutical and select automobile stocks, impacted by Britain's exit from the European Union (Brexit), have recouped their losses and are trading higher than the levels they were trading a day prior to the result."The exposure of these firms to Europe is eight-10 per cent of the total exports, so the impact is likely to be contained," said G Chokkalingam, founder, Equinomics Research. The rally has also aided the recovery.The information technology pack, however, continues to languish with key stocks trading one-five per cent below the pre-Brexit level."IT will take some time to recover as a lot of contracts are up for renewal and buyers in the euro region might want to postpone their decision till clarity emerges," said Deven Choksey, managing director, KR Choksey Shares.Tata group companies have a large exposure in the UK and EU, and Tata Motors and Tata Steel are also below the pre-Brexit levels.
 "Pharma recovers, tech lags after Brexit")
USFDA boost for pharma shares; Strides, Alembic up over 7% in a week
Dr Reddy's, Lupin, Cipla, Marksans Pharma, Sanofi India, Aurobindo and JB Chemicals gain over 5% each in one week.
 "USFDA boost for pharma shares; Strides, Alembic up over 7% in a week")
Local growth a challenge for pharma companies
Profitability and growth in the US remain soft; sluggish sales in India add to concerns
 "Local growth a challenge for pharma companies")
Govt weighs relaxing FDI norms in brownfield pharma cos
FDI in the sector is a contentious issue as concerns have been raised over some M&As of Indian pharma companies by foreign giants
 "Govt weighs relaxing FDI norms in brownfield pharma cos")
FY17 could be a better year for pharma majors
With most concerns priced in, investors may start bottom-fishing as valuations look reasonable
 "FY17 could be a better year for pharma majors")
Pharmaceutical sector posts 12% growth in February
Price hikes, new launches help sector maintain average of 12.9% since April 2015, but was lower against February 2015 growth of 18.9%
Pharma crusader Dinesh Thakur takes India's drug regulators to court
Files a PIL suit in the Supreme Court accusing them of failing to enforce rules on drug safety
 "Pharma crusader Dinesh Thakur takes India's drug regulators to court")
Kiran Mazumdar-Shaw backs move to have separate pharma ministry
She said there is confusion and chaos in the pharma sector due to multi-ministerial control
 "Kiran Mazumdar-Shaw backs move to have separate pharma ministry")
